Trade Ideas August 28, 2026 10:47 AM

Himax (HIMX) - Buy on Signs of Automotive Display Recovery; Tactical Swing Trade

Upgrade to Buy as automotive display demand, LCoS traction, and dividends reduce downside; trade plan with entry, stop, and target.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
HIMX

Himax Technologies looks positioned to benefit from an upturn in automotive display spending and continued wins in AR/AI microdisplays. With a market cap of $2.37B, modest yield and active product ramps, we upgrade to Buy for a tactical swing trade: entry $14.00, stop $12.50, target $18.00 over the next 45 trading days.

Himax (HIMX) - Buy on Signs of Automotive Display Recovery; Tactical Swing Trade
HIMX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Upgrade to Buy - entry $14.00, stop $12.50, target $18.00; mid-term horizon (45 trading days).
  • Market cap $2.37B; P/E ~69 and P/B ~2.67; dividend yield ~1.72% (paid 07/10/2026).
  • Product ramps in HX85200 OLED touch IC and Front-lit LCoS microdisplays plus automotive display exposure are the primary catalysts.
  • Technicals neutral - SMA cluster ~ $14, RSI ~48; short interest has fallen from peak indicating lighter short pressure.

Hook & Thesis

Himax Technologies (HIMX) has a strong line of display imaging and driver IC products, and recent product ramps plus industry coloration in automotive displays argue for upside from the stock's current level. We are upgrading the name to Buy and proposing a tactical swing trade: enter at $14.00, stop at $12.50, and target $18.00 with a horizon set as mid term (45 trading days).

The rationale is straightforward: the company is executing on multiple product wins that map directly into higher-margin, higher-content automotive and AR opportunities, and management has leaned into returning cash to shareholders via a 25.2 cent ADS dividend paid 07/10/2026. The market already prices some growth - PE near 69 - but the stock is down sharply from its 52-week high of $25.09, offering room for a rebound if automotive OEM orders reaccelerate.

Business overview - why the market should care

Himax is a semiconductor solution provider focused on display imaging processing technologies. Key product lines include display drivers, timing controllers, wafer-level optics (WLO), liquid crystal on silicon (LCoS) microdisplays, CMOS image sensors, and power ICs. These address TV, laptop, monitor, mobile, AR/VR, cameras, and notably automotive displays and ADAS-related modules.

The reason investors should care is the structural content increase in vehicles: modern cabins are adding larger instrument clusters, central infotainment screens, and passenger displays. Himax sells driver ICs and LCoS solutions that fit into this secular trend. On top of that, Himax has visible traction in AR microdisplays and ultralow power AI endpoints - areas that carry favorable ASPs and stronger gross margins compared with commodity display drivers.

Supporting evidence and data points

  • Market cap sits at $2.37B, with shares outstanding ~170.48M and a float of 170.48M.
  • Valuation metrics: P/E ~69.32 and P/B ~2.67, indicating the market expects continued growth but leaves room for re-rating if revenue and margin expansion follow product ramps.
  • 52-week range shows meaningful volatility: low $6.85 (11/21/2025) and high $25.09 (06/02/2026). The current price near $13.93 sits roughly mid-range and implies a substantial recovery to prior highs is possible if catalysts materialize.
  • Operational signals: the HX85200 OLED touch controller entered mass production in Q1 2026 for IT applications, and Himax showcased Front-lit LCoS microdisplays and WiseEye endpoint AI at CES 2026. The company also announced a strategic LCoS partnership with AUO that is being evaluated by top-tier AR customers.
  • Capital returns: Himax declared a cash dividend for FY2025 of $0.252 per ADS (paid 07/10/2026), with an indicated dividend yield near 1.72% and a 100% payout ratio of last year’s profit according to company statements. That payout flags the company’s healthy cash flow profile and management confidence in near-term cash generation.

Technical and market structure context

The ten to fifty day moving averages are clustered: SMA-10 at $14.01, SMA-20 at $14.17, SMA-50 at $14.18; shorter EMAs sit slightly below those levels (EMA-9 $13.96, EMA-21 $14.02). Momentum indicators show neutral to mildly bearish readings: RSI around 48 and MACD slightly negative. Average volumes show institutional interest with a two-week average around 886k, though recent daily volume has been lower. Short interest has declined from peaks earlier in the year (from ~7.26M to ~4.49M on 08/14/2026), suggesting reduced pressure from short sellers and potential for squeeze dynamics if sentiment improves.

Valuation framing

At a $2.37B market cap and P/E of ~69, Himax is priced like a growth company. That multiple reflects the market’s expectations for higher-margin product ramps (AR microdisplays, automotive displays, and AI endpoints). Historically the stock has traded as high as $25.09, implying significant upside if revenue and margin guidance catch up with expectations. There are no direct peers in this dataset to compare multiples, so the pragmatic view is to treat current valuation as conditional: it is expensive on trailing earnings but not outlandish if Himax can demonstrate sustainable content gains in automotive and AR segments.

Catalysts

  • Automotive demand rebound - OEM orders for display drivers and timing controllers could accelerate ASPs and volumes.
  • Production ramps for HX85200 OLED touch IC (entered mass production Q1 2026) translating into revenue recognition in upcoming quarters.
  • Commercial adoption of Front-lit LCoS microdisplays with AUO for AR glasses - evaluations are underway and could become design wins with tier-1 customers.
  • Substantial dividend and cash returns - continuing payouts signal cash generation and could attract yield-seeking investors supporting the share price.
  • Industry events and partnerships showcased at CES 2026 that could convert to commercial deals in H2 2026 and into 2027.

Trade plan (actionable)

Thesis: Buy into an early-stage recovery in automotive display content and higher-value AR microdisplay ramps.

Plan element Detail
Entry $14.00
Stop loss $12.50
Target $18.00
Trade direction Long
Horizon Mid term (45 trading days) - enough time to see OEM order flow pick up and leading product ramps translate to reported revenue.

Why 45 trading days? Automotive procurement cycles are longer than consumer electronics, but the market often reacts quickly to design-win headlines and early production notices. A 45 trading day horizon gives time for at least one quarter of trading reaction post-news flow without extending into long-term execution risk.

Risks and counterarguments

Below are the principal risks to the trade and a counterargument to our bullish thesis.

  • Automotive demand could stay weak. If OEMs continue to delay refresh programs or prioritize costs over content, Himax’s automotive-related revenues may not materialize quickly. That would compress the share price and keep the multiple elevated relative to realized growth.
  • Execution risk on new products. Mass production announcements (like HX85200) do not guarantee volume shipments or stable gross margins. Yield issues or slower-than-expected OEM adoption could delay revenue recognition.
  • High valuation sensitivity. With a trailing P/E of ~69, any earnings miss or margin compression can lead to outsized downside moves versus peers in more mature segments.
  • Macroeconomic/auto cycle risk. An economic slowdown or a deceleration in vehicle sales would hit automotive content vendors first, and Himax is not immune.
  • Competitive pressure. Large integrated suppliers or new entrants in microdisplays and touch controllers could pressure pricing and mix.

Counterargument: One could reasonably argue that much of Himax’s positive news is already priced in - the stock traded as high as $25 earlier this year on similar narratives. If orders stall or if the company fails to translate design wins into high-volume production, the valuation could revert lower quickly. That risk is why the trade uses a relatively tight stop and a mid-term horizon.

What would change our mind

We would abandon the Buy and trim exposure if any of the following occur: a) Himax issues guidance materially below expectations or delays mass production schedules; b) automotive OEM order commentary softens across multiple customers; c) margins deteriorate due to yield or pricing pressure; or d) our stop at $12.50 is triggered, signaling the market has re-priced a longer recovery timeline.

Conclusion

Himax has visible product ramps in higher-value display segments and a dividend that underscores cash generation. The share price is attractively positioned relative to its 52-week high and the company’s line-up in automotive displays and AR microdisplays. For traders willing to accept execution and cycle risk, a tactical long at $14.00 with a $12.50 stop and a $18.00 target over 45 trading days provides asymmetric upside while limiting downside. Monitor order flow from automotive OEMs, upcoming quarterly reporting, and any updates on mass production ramps closely - those items will either validate the upgrade to Buy or prompt a reassessment.

Key action items

  • Enter at $14.00, set stop at $12.50, target $18.00.
  • Watch quarterly commentary and revenue recognition tied to HX85200 and LCoS ramps.
  • Re-evaluate position if guidance changes, major OEM announcements are delayed, or stop is hit.

Risks

  • Automotive OEM demand could remain muted, delaying meaningful revenue contribution from display content.
  • Execution risk: mass production announcements may not translate into immediate volume shipments or stable margins.
  • High valuation sensitivity (P/E ~69) means earnings misses could produce sharp downside.
  • Competitive pressures in microdisplays and touch controllers could compress ASPs and margins.

More from Trade Ideas

AXT: Buy the InP Story on a Pullback — Growth Justifies a Risky Valuation Aug 28, 2026 After the Beat: Why I'm Adding to NVDA and How I'm Positioning the Trade Aug 28, 2026 Buy the Launch: Speculative Long on SpaceX as Debt Funds an AI Pivot Aug 28, 2026 BioCryst (BCRX): A Two-Front Play on HAE — Trade It as a Risk-Reward Swing to Clinical and Commercial Upside Aug 28, 2026 Initiating Buy: SK hynix — Revenue Edge and Undervalued Relative to Micron Aug 28, 2026